Healthy pregnancy hub

Fluoxetine (Prozac®)

Last Update: 30 Sep 2026

Medication
Welcome to our fact sheet on fluoxetine during pregnancy and lactation. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here (June 2026).

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on the one from MotherToBaby with United States information and has been reviewed by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation.

1. What is fluoxetine? 

Fluoxetine is a medication that has been used to treat depression, obsessive-compulsive disorder (OCD), Tourette’s syndrome, bulimia nervosa, panic disorder, and premenstrual dysphoric disorder (PMDD). Fluoxetine has also been used to treat body dysmorphic disorder, hot sweats, posttraumatic stress disorder (PTSD), and Raynaud’s phenomenon. Some brand names in the United States for fluoxetine are Prozac®, Prozac Weekly®, Rapuflux®, Selfemra®, and Sarafem®. Fluoxetine belongs to the class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). For more information on anxiety and depression, please see our factsheets on these topics.

Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take your medication. They can talk with you about the benefits of treating your condition and the risks of untreated illness during pregnancy.

If you plan to stop this medication, your healthcare professional might suggest that you slowly lower the dose instead of stopping all at once. Some people might have a return of their symptoms (relapse) if they stop this medication during pregnancy. If you stop taking this medication, it is important to have other forms of support in place such as counseling or therapy, and a plan to restart the medication after delivery, if needed. Stopping this medication suddenly can cause some people to have withdrawal symptoms. It is not known if or how withdrawal might affect pregnancy.

2. What does research say about the safety during pregnancy?

I take fluoxetine. Can it make it harder for me to get pregnant?  

Fluoxetine has been studied in people receiving medical treatments for trouble getting pregnant. In these studies, those who took fluoxetine became pregnant at the same rate as people who did not take fluoxetine.

Does taking fluoxetine increase the chance of miscarriage?

Miscarriage is common and can occur in any pregnancy for many different reasons. A small number of studies did not find a greater chance of miscarriage when fluoxetine was used in pregnancy. 

Does taking fluoxetine increase the chance of birth defects?

Out of all babies born each year, about 3 out of 100 (3%) will have a birth defect. We look at research studies to try to understand if an exposure, like fluoxetine, might increase the chance of birth defects in a pregnancy.  

Some studies have suggested an increased chance of heart defects or other birth defects with fluoxetine use. However, most studies have not found an increased chance of birth defects with fluoxetine use, and there is no proven increased chance of birth defects directly related to fluoxetine. 

There are reports of more than 10,000 pregnancies exposed to fluoxetine during the first trimester, when many major birth defects can happen. No pattern of birth defects has been found. Overall, fluoxetine use is not expected to increase the chance of birth defects. 

Does taking fluoxetine in pregnancy increase the chance of other pregnancy-related problems?

Some studies suggest a higher chance of preterm delivery (birth before week 37) or low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth) with the use of fluoxetine in pregnancy. However, research has also shown that when conditions such as depression or anxiety are untreated or undertreated during pregnancy, there could be an increased chance of pregnancy complications. This makes it hard to know if it is the medication, the underlying condition, or other factors that might increase the chance for these problems. 

Some, but not all, studies have suggested that when SSRIs are taken during the second half of pregnancy, babies might have an increased chance for a serious lung condition called persistent pulmonary hypertension in newborns (PPHN). PPHN happens in 1 or 2 out of 1,000 births. A recent report combining the results of several studies suggested that the chance of PPHN might be higher with SSRI use during pregnancy. However, it is not clear if this is due to the medication or other factors that are more common among people who take SSRIs, such as smoking. Overall, the chance of PPHN when an SSRI is used during pregnancy is less than 1/100 (less than 1%). 

I need to take fluoxetine throughout my entire pregnancy. Will it cause withdrawal symptoms in my baby after birth?

The use of fluoxetine during pregnancy and/or in the third trimester can cause temporary symptoms in newborns soon after birth. These symptoms are sometimes referred to as withdrawal. Symptoms include being irritable and/or jittery, crying, tight muscles, trouble breathing, unusual sleep patterns, tremors (shivers), and/or trouble eating. In most cases symptoms are mild and go away in a few weeks with no treatment, or with only supportive care. Not all babies exposed to fluoxetine will have these symptoms. There might be a higher chance for withdrawal symptoms if other psychiatric medications are also taken with fluoxetine during pregnancy. It is important that your healthcare professionals know you are taking fluoxetine so that if symptoms occur your baby can get the care that is best for them. 

Does taking fluoxetine in pregnancy affect future behavior or learning for the child?

A few studies have looked at the development from 16 months to 7 years of age and found no differences between children who were exposed to fluoxetine during pregnancy and those who were not. Most studies have not found an increased chance of attention-deficit/hyperactivity disorder (ADHD) in children exposed to SSRIs, such as fluoxetine, during pregnancy. Most studies also have not found an increased chance of autism spectrum disorders (ASD) after adjusting for other factors such as the illness of the mother or the birthing parent.

3. Lactating while taking fluoxetine

Fluoxetine gets into human milk and most reports find no side effects in nursed babies. In a small number of cases, irritability, vomiting, diarrhea, and less sleep have been reported. One study noted slightly less weight gain in infants exposed to fluoxetine through human milk; however, this would likely only be an issue if the infant’s weight gain was already a concern. One study showed that mental and physical development was normal for infants exposed to fluoxetine in human milk in their first year of life. If you suspect the baby has any symptoms (such as irritability, vomiting, diarrhea, trouble sleeping, or trouble gaining weight) contact the child’s healthcare professional. 

Some older product labels for fluoxetine recommend against using this medication if you are breast/chestfeeding. More recent product labels do not include this recommendation. The benefit of treating your condition might outweigh possible risks of untreated illness. Your healthcare professionals can talk with you about using fluoxetine and what treatment is best for you. Be sure to talk to your healthcare provider about all your lactation questions. 

4. What about fathers and sperm donors?

If a male takes fluoxetine, could it affect fertility or increase the chance of birth defects?

Fluoxetine and other SSRIs can cause sexual side effects, such as lower sexual desire or problems with ejaculation. These effects can affect a male’s fertility (ability to make healthy sperm). Studies in a small number of males have found that long-term fluoxetine use may affect sperm quality, although it remained within the normal range. Sperm quality improved after fluoxetine was stopped. In general, exposures that fathers and sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here.

Key points

  • Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant used to treat depression, anxiety, and other mental health conditions.  
  • Current studies do not show that fluoxetine increases the risk of birth defects.  
  • Some studies suggest a slightly higher chance of preterm birth or low birth weight. However, untreated depression or anxiety during pregnancy may also increase these risks.  
  • Taking fluoxetine near the end of pregnancy may cause temporary symptoms in some newborns, such as irritability, tremors, or feeding difficulties. These symptoms are usually mild and go away within a few weeks.  
  • Fluoxetine passes into human milk, but most studies have not reported side effects in nursed infants.  
  • In males, fluoxetine may reduce sexual desire or temporarily affect sperm quality, but it is not expected to increase risks to a pregnancy.  
  • Always talk with your healthcare professional before starting, changing, or stopping fluoxetine during pregnancy or lactation.

References

Please click here for references.

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Laurie Beauvilliers
Université de Montréal
Judith Cottin
Sherif Eltonsy
University of Manitoba
Catriona Hippman
University of British Columbia
Émy Roberge
Centre hospitalier universitaire Sainte-Justine

Associated Fact Sheets

You want to know more about this topis? Discover our associated Fact Sheets!

Associated Resources

Want to know more? Discover our other contents associated to the topic.

Our interactive tools

Stay inform with our monthly newsletter.

Subscribe here!

Explore our reading assistance tool.

Test them out today!

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University